Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research (2017)
- Authors:
- USP affiliated authors: PEREIRA, CARLOS ALBERTO DE BRAGANCA - IME ; MIGUEL FILHO, EURIPEDES CONSTANTINO - FM
- Unidades: IME; FM
- DOI: 10.1016/j.pnpbp.2017.06.037
- Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO; FENÓTIPOS; ALGORITMOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Progress in neuro-psychopharmacology & biological psychiatry
- ISSN: 0278-5846
- Volume/Número/Paginação/Ano: v. 79, p. 206-212, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SHAVITT, Roseli G. et al. Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research. Progress in neuro-psychopharmacology & biological psychiatry, v. 79, p. 206-212, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2017.06.037. Acesso em: 13 fev. 2026. -
APA
Shavitt, R. G., Requena, G., Alonso, P., Zai, G., Costa, D. L. C., Pereira, C. A. de B., et al. (2017). Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research. Progress in neuro-psychopharmacology & biological psychiatry, 79, 206-212. doi:10.1016/j.pnpbp.2017.06.037 -
NLM
Shavitt RG, Requena G, Alonso P, Zai G, Costa DLC, Pereira CA de B, Rosário MC do, Morais I, Fontenello L, Cappi C, Kennedy J, Menchon JM, Miguel Filho EC, Richter PMA. Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2017 ; 79 206-212.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.06.037 -
Vancouver
Shavitt RG, Requena G, Alonso P, Zai G, Costa DLC, Pereira CA de B, Rosário MC do, Morais I, Fontenello L, Cappi C, Kennedy J, Menchon JM, Miguel Filho EC, Richter PMA. Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research [Internet]. Progress in neuro-psychopharmacology & biological psychiatry. 2017 ; 79 206-212.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.06.037 - Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder
- The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder
- Association study between the-62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder
- Quetotaxia dorsal e tagmatização em actinotrichida (Acariformes)
- Notice of Retraction and Replacement. Lopes et al. Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized [Carta]
- Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns
- A double-blind, randomized, controlled trial of fluoxetine plus Quetiapine or Clomipramine versus Fluoxetine Plus Placebo for obsessive-compulsive disorder
- Higher prevalence of obsessive-compulsive spectrum disorders in rheumatic fever
- A double-blind randomized controlled trial of fluoxetine plus quetiapine or clomipramine vs. Fluoxetine plus placebo for obsessive-compulsive disorder
- Trajectory in obsessive-compulsive disorder comorbidities
Informações sobre o DOI: 10.1016/j.pnpbp.2017.06.037 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
2879978.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
